Lindbrook Capital’s Organogenesis Holdings ORGO Stock Holding History

Lindbrook Capital’s Portfolio ORGO Stock Details ORGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$924	Buy	214 +24	+13%	+$97	﹤0.01%	2481
2024 Q4	$608	Hold	190	–	–	﹤0.01%	2576
2024 Q3	$543	Sell	190 -591	-76%	-$1.66K	﹤0.01%	2647
2024 Q2	$2.19K	Buy	+781	New	+$2.1K	﹤0.01%	2318
2023 Q4	–	Sell	-1,156	Closed	-$3.68K	–	2785
2023 Q3	$3.68K	Buy	1,156 +421	+57%	+$1.34K	﹤0.01%	1909
2023 Q2	$2.44K	Buy	735 +474	+182%	+$1.4K	﹤0.01%	2074
2023 Q1	$556	Buy	+261	New	+$645	﹤0.01%	2581
2022 Q4	–	Sell	-65	Closed	–	–	2961
2022 Q3	$0	Buy	+65	New	+$294	﹤0.01%	2831

Other funds holding ORGO

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Lindbrook Capital's ORGO Position: Q1 2025 in Review

Lindbrook Capital increased its Organogenesis Holdings (ORGO) stake by 13% in Q1 2025, buying an estimated $97 and bringing the position to 214 shares worth $924. The position accounts for ﹤0.01% of the portfolio, ranked #2481.

Lindbrook Capital first reported a position in ORGO in Q3 2022 and has held it in 8 quarters since. The position peaked at $3.68K in Q3 2023. 136 funds tracked by Wall St. Rank hold ORGO as of Q1 2025.

Lindbrook Capital held 214 shares of Organogenesis Holdings worth $924 as of Q1 2025.
Lindbrook Capital bought 24 Organogenesis Holdings shares in Q1 2025, an estimated $97.
Organogenesis Holdings made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #2481 holding.
Lindbrook Capital first reported a position in Organogenesis Holdings in Q3 2022 and has held it in 8 quarters since.
Lindbrook Capital's Organogenesis Holdings position peaked at $3.68K in Q3 2023.
136 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.